Relmada Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 11/14/2025 | 1.84 M | $3.70 M | 4,476.76% | 5.55% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 740.01 K | $1.49 M | 0.00% | 2.23% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 693.24 K | $1.39 M | 100.00% | 2.09% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 582.54 K | $1.17 M | -5.96% | 1.76% |
| BLACKROCK, INC. | 11/12/2025 | 508.00 K | $1.02 M | 0.00% | 1.53% |
| VANGUARD GROUP INC | 11/07/2025 | 418.58 K | $841.35 K | 14.97% | 1.26% |
| ADVISORSHARES INVESTMENTS LLC | 11/05/2025 | 403.49 K | $811.01 K | 1.76% | 1.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 296.22 K | $595.53 K | -2.03% | 0.89% |
| MARSHALL WACE, LLP | 11/13/2025 | 272.05 K | $546.83 K | 76.01% | 0.82% |
| DEUTSCHE BANK AG\ | 11/13/2025 | 224.85 K | $451.94 K | 0.00% | 0.68% |
| CI PRIVATE WEALTH, LLC | 11/14/2025 | 206.67 K | $402.00 K | 0.00% | 0.62% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 173.61 K | $348.96 K | 81.95% | 0.52% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 169.70 K | $341.10 K | 13.06% | 0.51% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 10/29/2025 | 163.34 K | $328.31 K | 0.00% | 0.49% |
| RBF CAPITAL, LLC | 11/14/2025 | 163.26 K | $328.16 K | 0.00% | 0.49% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 138.42 K | $278.23 K | 110.36% | 0.42% |
| STATE STREET CORP | 11/14/2025 | 101.82 K | $204.66 K | -4.60% | 0.31% |
| MGO ONE SEVEN LLC | 10/24/2025 | 100.00 K | $201.00 K | 0.00% | 0.30% |
| JANE STREET GROUP, LLC | 11/14/2025 | 85.67 K | $172.19 K | -25.09% | 0.26% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 66.00 K | $132.66 K | 100.00% | 0.20% |
| UBS GROUP AG | 11/13/2025 | 59.79 K | $120.17 K | -66.87% | 0.18% |
| NORTHERN TRUST CORP | 11/14/2025 | 59.02 K | $118.64 K | -0.92% | 0.18% |
| LMR PARTNERS LLP | 11/14/2025 | 55.60 K | $111.76 K | 0.90% | 0.17% |
| SIMPLEX TRADING, LLC | 11/12/2025 | 53.08 K | $106.00 K | 2,087.14% | 0.16% |
| APRICUS WEALTH, LLC | 10/21/2025 | 47.46 K | $95.40 K | 0.00% | 0.14% |
| TWO SIGMA ADVISERS, LP | 11/14/2025 | 38.80 K | $77.99 K | 54.58% | 0.12% |
| CARTESIAN GROWTH CORP | 11/06/2025 | 31.98 K | $64.27 K | 0.00% | 0.10% |
| ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC | 11/12/2025 | 25.00 K | $50.25 K | 0.00% | 0.08% |
| PANDORA WEALTH, INC. | 11/03/2025 | 20.00 K | $40.20 K | 0.00% | 0.06% |
| CITADEL ADVISORS LLC | 11/14/2025 | 18.30 K | $36.78 K | 100.00% | 0.06% |
| TORTOISE INVESTMENT MANAGEMENT, LLC | 11/13/2025 | 13.91 K | $27.96 K | -35.83% | 0.04% |
| LIDO ADVISORS, LLC | 11/14/2025 | 13.91 K | $27.95 K | 0.00% | 0.04% |
| PENSIONMARK FINANCIAL GROUP, LLC | 10/15/2025 | 10.64 K | $21.40 K | -50.82% | 0.03% |
| BARCLAYS PLC | 11/12/2025 | 10.00 K | $20.10 K | 100.00% | 0.03% |
| BEDEL FINANCIAL CONSULTING, INC. | 11/07/2025 | 10.00 K | $20.10 K | 0.00% | 0.03% |
| AMERICAN CAPITAL ADVISORY, LLC | 10/28/2025 | 1.95 K | $3.93 K | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 1.58 K | $3.18 K | -74.45% | 0.00% |
| MORGAN STANLEY | 11/14/2025 | 1.04 K | $2.09 K | 21.95% | 0.00% |
| FARTHER FINANCE ADVISORS, LLC | 10/14/2025 | 838 | $1.68 K | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 263 | $528 | -18.83% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 102 | $205 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 11/13/2025 | 93 | $187 | 6.90% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 5 | $9 | 0.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 2 | $4 | 0.00% | 0.00% |
| FRONT ROW ADVISORS LLC | 11/17/2025 | 2 | $4 | -33.33% | 0.00% |
| JPMORGAN CHASE & CO | 11/26/2025 | 0 | $0 | -100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 11/12/2025 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUND SWELL CAPITAL, LLC | 11/06/2025 | 0 | $0 | -100.00% | 0.00% |
Relmada Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 67 institutional investors and hedge funds held shares of Relmada Therapeutics, Inc.. The most heavily invested institutionals were:
Ikarian Capital, LLC: 1.84 M
DRIEHAUS CAPITAL MANAGEMENT LLC: 740,006
BOOTHBAY FUND MANAGEMENT, LLC: 693,236
ACADIAN ASSET MANAGEMENT LLC: 582,543
BlackRock, Inc.: 508,000
VANGUARD GROUP INC: 418,580
23.32% of Relmada Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 9.53 M shares in the last 24 months. This purchase volume represents approximately $38.11 M in transactions.